15/10/2024
We are thrilled to announce that Montefiore Life Sciences participated in one of the largest global gatherings of pharmaceutical and biotech companies, CPHI 2024, held in Milan from October 8-10. This prestigious event offered us the opportunity to connect with top industry leaders, build new partnerships, and expand our global network. During this prestigious event, we engaged in productive discussions with leading companies from countries including China, Spain, Greece, Saudi Arabia, Switzerland, Italy, and beyond. These interactions provided us with invaluable opportunities to explore potential partnerships and present Montefiore Life Sciences' comprehensive Regulatory Affairs services. Our team emphasized how we support our clients by navigating complex regulatory landscapes and ensuring successful product approvals across multiple markets.
The connections and insights gained at CPHI Milan 2024 have reinforced our commitment to fostering global collaboration and innovation within the life sciences sector. We are enthusiastic about the opportunities that have emerged from this event and look forward to expanding our partnerships with industry leaders worldwide.
Montefiore Life Sciences remains dedicated to offering strategic regulatory solutions, supporting companies in accelerating their time-to-market, and ensuring compliance with international standards.
We thank everyone we met at CPHI 2024 and look forward to continued collaboration.
